WH
FLXN

William Harnisch’s Flexion Therapeutics, Inc. FLXN Stock Holding History

William Harnisch’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-222,965
Closed -$4.17M – 57
2018
Q3 		$4.17M Sell
222,965
-474,035
-68% -$10.9M 1.05% 10
2018
Q2 		$18M Buy
697,000
+28,500
+4% +$740K 3.31% 5
2018
Q1 		$15M Buy
668,500
+20,252
+3% +$494K 2.9% 6
2017
Q4 		$16.2M Buy
648,248
+548,248
+548% +$13.4M 2.33% 9
2017
Q3 		$2.42M Buy
+100,000
New +$2.35M 0.39% 18

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

William Harnisch's FLXN Position: Q4 2018 in Review

William Harnisch sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2018, closing a stake of 222,965 shares — an estimated $4.17M sold.

William Harnisch first reported a position in FLXN in Q3 2017 and held it in 5 quarters. The position peaked at $18M in Q2 2018. 125 funds tracked by Wall St. Rank hold FLXN as of Q4 2018.

  • William Harnisch reported no remaining Flexion Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
  • William Harnisch sold 222,965 Flexion Therapeutics, Inc. shares in Q4 2018, an estimated $4.17M.
  • William Harnisch first reported a position in Flexion Therapeutics, Inc. in Q3 2017 and held it in 5 quarters.
  • William Harnisch's Flexion Therapeutics, Inc. position peaked at $18M in Q2 2018.
  • 125 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2018.

Based on Peconic Partners's 13F filing for Q4 2018, filed 14 Feb 2019.